Pharmaceutical Company
Medical Device Tax Repeal; Stop Corporate Inversions Act (S.2360) (H.R.4679); issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013 (S.232) (H.R.523) general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013 general Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement Ensuring Safe Access to Prescription Medication Act of 2014 (S.2825)
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
BILL K BREWSTER DAVID JORY CHRISTOPHER BOWLIN (Committee 1999-2001) BILL K BREWSTER DAVID JORY CHRISTOPHER BOWLIN (Committee 1999-2001) BILL K BREWSTER DAVID JORY CHRISTOPHER BOWLIN (Committee 1999-2001) BILL K BREWSTER DAVID JORY CHRISTOPHER BOWLIN (Committee 1999-2001)
Committee 1999-2001 Committee 1999-2001 Committee 1999-2001 Committee 1999-2001